Literature DB >> 29362820

Subtherapeutic valproic acid plasma concentrations under concomitant dipyrone therapy in an epilepsy patient-a case report.

Benedict Morath1,2,3, K Green4,5, M Zaradzki6, J Heid7, M Karck6, T Hoppe-Tichy4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29362820     DOI： 10.1007/s00228-018-2417-5

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  11 in total

Review 1.  [Drug interactions with the cytochrome P-450 system].

Authors:  M Martin-Facklam; J Drewe; W E Haefeli
Journal:  Dtsch Med Wochenschr       Date:  2000-01-21       Impact factor: 0.628

2.  Rapid clinical induction of bupropion hydroxylation by metamizole in healthy Chinese men.

Authors:  Wen-Jie Qin; Wei Zhang; Zhao-Qian Liu; Xiao-Ping Chen; Zhi-Rong Tan; Dong-Li Hu; Dan Wang; Lan Fan; Hong-Hao Zhou
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

3.  Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype.

Authors:  Tony K L Kiang; Ping C Ho; M Reza Anari; Vincent Tong; Frank S Abbott; Thomas K H Chang
Journal:  Toxicol Sci       Date:  2006-08-31       Impact factor: 4.849

Review 4.  Psychotropic drug interactions with valproate.

Authors:  Jessica Fleming; Manoranjenni Chetty
Journal:  Clin Neuropharmacol       Date:  2005 Mar-Apr       Impact factor: 1.592

5.  Plasma protein binding of dipyrone metabolites in man.

Authors:  E Zylber-Katz; L Granit; M Levy
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients.

Authors:  Lan Tan; Jin-Tai Yu; Yan-Ping Sun; Jiang-Rong Ou; Jing-Hui Song; Yang Yu
Journal:  Clin Neurol Neurosurg       Date:  2010-01-20       Impact factor: 1.876

Review 7.  Clinical pharmacokinetics of dipyrone and its metabolites.

Authors:  M Levy; E Zylber-Katz; B Rosenkranz
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

Review 8.  Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

Authors:  Wolfgang Löscher
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 9.  The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice.

Authors:  Gin S Malhi; Danielle Adams; Catherine M Cahill; Seetal Dodd; Michael Berk
Journal:  Drugs       Date:  2009-10-22       Impact factor: 9.546

10.  Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizole.

Authors:  T Saussele; O Burk; J K Blievernicht; K Klein; A Nussler; N Nussler; J G Hengstler; M Eichelbaum; M Schwab; U M Zanger
Journal:  Clin Pharmacol Ther       Date:  2007-03-07       Impact factor: 6.875
View more
  1 in total

1.  Gephyrin and CYP2C9 Genetic Polymorphisms in Patients with Pharmacoresistant Epilepsy.

Authors:  Hamdy N El-Tallawy; Sawsan Abuhamdah; Ahmed Y Nassar; Wafaa M A Farghaly; Tahia H Saleem; Sara A Atta; Ayat A Sayed; Amal M Tohamy; Mohammed H Hassan
Journal:  Pharmgenomics Pers Med       Date:  2021-09-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.